MutScore (Livesey and Marsh 2025)
Configuration of MutScore: scores from the tool's own published code or score files; no release or settings beyond its name are recorded.
Overview
An explanatory profile has not yet been reviewed for this record.
Consult the linked sources for architecture or protocol details. Missing evidence is not evidence of a missing capability.
Evaluations and results
6 evaluations · 7 results. Different protocols are not a single leaderboard.
Sorted by Pairwise win rate (average pairwise win rate against all other VEPs, |Spearman| with DMS on shared variants, 36 human DMS sets) (higher is better). The best value in each column is highlighted. Decimals are rounded for display; each value links to the printed value and its source.
| Tested configuration | Protocol and dataset | Pairwise win rate (average pairwise win rate against all other VEPs, |Spearman| with DMS on shared variants, 36 human DMS sets) | Pairwise win rate (average pairwise win rate against all other VEPs, |Spearman| with DMS on shared variants, direct DMS assays only) | Pairwise win rate (average pairwise win rate against all other VEPs, |Spearman| with DMS on shared variants, indirect DMS assays only) | Pairwise win rate (average pairwise win rate against all other VEPs, |Spearman| with DMS on shared variants, SNV-accessible substitutions only) | Pairwise win rate (average pairwise win rate against all other VEPs, |Spearman| with DMS, SNV-accessible substitutions, missing predictions filled with the VEP's most benign score) | Pairwise win rate (average pairwise win rate against all other VEPs, per-protein AUROC on shared variants, ClinVar P/LP versus gnomAD v4.1 missense, proteins with at least 10 of each) | Pairwise win rate (average pairwise win rate against the five top-ranked VEPs (column top_5_winrate; the five are not listed in the table), |Spearman| with DMS on shared variants, 36 human DMS sets) |
|---|---|---|---|---|---|---|---|---|
| MutScore (Livesey and Marsh 2025)Evaluation | Livesey and Marsh 2025 DMS benchmark: pairwise |Spearman| win rate, all 36 DMS sets, Livesey and Marsh 2025 human DMS benchmark set (36 proteins) | 63.4% | Not reported | Not reported | Not reported | Not reported | Not reported | 8.64% |
| MutScore (Livesey and Marsh 2025)Evaluation | Livesey and Marsh 2025 clinical benchmark: pairwise AUROC win rate, ClinVar pathogenic versus gnomAD missense, Livesey and Marsh 2025 clinical set: ClinVar pathogenic versus gnomAD v4.1 missense (819 proteins) | Not reported | Not reported | Not reported | Not reported | Not reported | 76.6% | Not reported |
| MutScore (Livesey and Marsh 2025)Evaluation | Livesey and Marsh 2025 DMS benchmark: pairwise |Spearman| win rate, direct assays only, Livesey and Marsh 2025 human DMS benchmark set (36 proteins) | Not reported | 61.5% | Not reported | Not reported | Not reported | Not reported | Not reported |
| MutScore (Livesey and Marsh 2025)Evaluation | Livesey and Marsh 2025 DMS benchmark: pairwise |Spearman| win rate, indirect assays only, Livesey and Marsh 2025 human DMS benchmark set (36 proteins) | Not reported | Not reported | 64.8% | Not reported | Not reported | Not reported | Not reported |
| MutScore (Livesey and Marsh 2025)Evaluation | Livesey and Marsh 2025 DMS benchmark: pairwise |Spearman| win rate, SNV-accessible substitutions with gaps filled, Livesey and Marsh 2025 human DMS benchmark set (36 proteins) | Not reported | Not reported | Not reported | Not reported | 63.2% | Not reported | Not reported |
| MutScore (Livesey and Marsh 2025)Evaluation | Livesey and Marsh 2025 DMS benchmark: pairwise |Spearman| win rate, SNV-accessible substitutions only, Livesey and Marsh 2025 human DMS benchmark set (36 proteins) | Not reported | Not reported | Not reported | 63.4% | Not reported | Not reported | Not reported |
All 7 result rows with coverage, uncertainty and sources
Filter evaluations
Applied filters: All linked evaluations
| Tested configuration | Protocol and dataset | Finding | Evidence and details |
|---|---|---|---|
| Configuration: MutScore (Livesey and Marsh 2025) | Protocol: Livesey and Marsh 2025 clinical benchmark: pairwise AUROC win rate, ClinVar pathogenic versus gnomAD missense Dataset: Livesey and Marsh 2025 clinical set: ClinVar pathogenic versus gnomAD v4.1 missense (819 proteins) | 76.6% Pairwise win rate (average pairwise win rate against all other VEPs, per-protein AUROC on shared variants, ClinVar P/LP versus gnomAD v4.1 missense, proteins with at least 10 of each) percent · higher Uncertainty: Not reported by the source: Figure 3 error bars (standard error across comparisons) are not printed Coverage: 796/819 proteins with at least 10 ClinVar P/LP and 10 gnomAD missense variants scored by this VEP scored ('proteins' column, cell CJ8) | Independent external evaluation · Source checkedMethods, coverage and sourceLivesey and Marsh 2025 clinical benchmark: pairwise AUROC win rate, ClinVar pathogenic versus gnomAD missense Aggregation: Not reported Livesey and Marsh 2025, Supplementary Material 2 (Tables S1-S8); Livesey and Marsh 2025, Genome Biology 26:104 (Europe PMC full text XML) · Supplementary Material 2, sheet 'Table S8', cell CI8 (row 'MutScore', column 'rank_score') |
| Configuration: MutScore (Livesey and Marsh 2025) | Protocol: Livesey and Marsh 2025 DMS benchmark: pairwise |Spearman| win rate, all 36 DMS sets Dataset: Livesey and Marsh 2025 human DMS benchmark set (36 proteins) | 63.4% Pairwise win rate (average pairwise win rate against all other VEPs, |Spearman| with DMS on shared variants, 36 human DMS sets) percent · higher Uncertainty: Not reported by the source: Bootstrap standard deviations appear only as Figure 2 error bars; not printed Coverage: 35/36 human DMS datasets (one per protein) with predictions for this VEP scored ('proteins' column, cell CV31) | Independent external evaluation · Source checkedMethods, coverage and sourceMutScore: Livesey and Marsh 2025 DMS benchmark: pairwise |Spearman| win rate, all 36 DMS sets Livesey and Marsh 2025 DMS benchmark: pairwise |Spearman| win rate, all 36 DMS sets Aggregation: Not reported Livesey and Marsh 2025, Supplementary Material 2 (Tables S1-S8); Livesey and Marsh 2025, Genome Biology 26:104 (Europe PMC full text XML) · Supplementary Material 2, sheet 'Table S3', cell CU31 (row 'MutScore', column 'rank_score') |
| Configuration: MutScore (Livesey and Marsh 2025) | Protocol: Livesey and Marsh 2025 DMS benchmark: pairwise |Spearman| win rate, all 36 DMS sets Dataset: Livesey and Marsh 2025 human DMS benchmark set (36 proteins) | 8.64% Pairwise win rate (average pairwise win rate against the five top-ranked VEPs (column top_5_winrate; the five are not listed in the table), |Spearman| with DMS on shared variants, 36 human DMS sets) percent · higher Uncertainty: Not reported by the source: Bootstrap standard deviations appear only as Figure 2 error bars; not printed Coverage: Not reported scored / Not reported eligible | Independent external evaluation · Source checkedMethods, coverage and sourceMutScore: Livesey and Marsh 2025 DMS benchmark: pairwise |Spearman| win rate, all 36 DMS sets Livesey and Marsh 2025 DMS benchmark: pairwise |Spearman| win rate, all 36 DMS sets Aggregation: Not reported Livesey and Marsh 2025, Supplementary Material 2 (Tables S1-S8); Livesey and Marsh 2025, Genome Biology 26:104 (Europe PMC full text XML) · Supplementary Material 2, sheet 'Table S3', cell CW31 (row 'MutScore', column 'top_5_winrate') |
| Configuration: MutScore (Livesey and Marsh 2025) | Protocol: Livesey and Marsh 2025 DMS benchmark: pairwise |Spearman| win rate, direct assays only Dataset: Livesey and Marsh 2025 human DMS benchmark set (36 proteins) | 61.5% Pairwise win rate (average pairwise win rate against all other VEPs, |Spearman| with DMS on shared variants, direct DMS assays only) percent · higher Uncertainty: Not reported by the source: Bootstrap standard deviations appear only as Figure 2 error bars; not printed Coverage: Not reported scored / Not reported eligible | Independent external evaluation · Source checkedMethods, coverage and sourceMutScore: Livesey and Marsh 2025 DMS benchmark: pairwise |Spearman| win rate, direct assays only Livesey and Marsh 2025 DMS benchmark: pairwise |Spearman| win rate, direct assays only Aggregation: Not reported Livesey and Marsh 2025, Supplementary Material 2 (Tables S1-S8); Livesey and Marsh 2025, Genome Biology 26:104 (Europe PMC full text XML) · Supplementary Material 2, sheet 'Table S5', cell C30 (row 'MutScore', column 'rank_score_direct') |
| Configuration: MutScore (Livesey and Marsh 2025) | Protocol: Livesey and Marsh 2025 DMS benchmark: pairwise |Spearman| win rate, indirect assays only Dataset: Livesey and Marsh 2025 human DMS benchmark set (36 proteins) | 64.8% Pairwise win rate (average pairwise win rate against all other VEPs, |Spearman| with DMS on shared variants, indirect DMS assays only) percent · higher Uncertainty: Not reported by the source: Bootstrap standard deviations appear only as Figure 2 error bars; not printed Coverage: Not reported scored / Not reported eligible | Independent external evaluation · Source checkedMethods, coverage and sourceMutScore: Livesey and Marsh 2025 DMS benchmark: pairwise |Spearman| win rate, indirect assays only Livesey and Marsh 2025 DMS benchmark: pairwise |Spearman| win rate, indirect assays only Aggregation: Not reported Livesey and Marsh 2025, Supplementary Material 2 (Tables S1-S8); Livesey and Marsh 2025, Genome Biology 26:104 (Europe PMC full text XML) · Supplementary Material 2, sheet 'Table S5', cell B30 (row 'MutScore', column 'rank_score_indirect') |
| Configuration: MutScore (Livesey and Marsh 2025) | Protocol: Livesey and Marsh 2025 DMS benchmark: pairwise |Spearman| win rate, SNV-accessible substitutions with gaps filled Dataset: Livesey and Marsh 2025 human DMS benchmark set (36 proteins) | 63.2% Pairwise win rate (average pairwise win rate against all other VEPs, |Spearman| with DMS, SNV-accessible substitutions, missing predictions filled with the VEP's most benign score) percent · higher Uncertainty: Not reported by the source: Bootstrap standard deviations appear only as Figure 2 error bars; not printed Coverage: 35/36 human DMS datasets (one per protein) with predictions for this VEP scored ('proteins' column, cell C32) | Independent external evaluation · Source checkedMethods, coverage and sourceLivesey and Marsh 2025 DMS benchmark: pairwise |Spearman| win rate, SNV-accessible substitutions with gaps filled Aggregation: Not reported Livesey and Marsh 2025, Supplementary Material 2 (Tables S1-S8); Livesey and Marsh 2025, Genome Biology 26:104 (Europe PMC full text XML) · Supplementary Material 2, sheet 'Table S7', cell B32 (row 'MutScore', column 'rank_score') |
| Configuration: MutScore (Livesey and Marsh 2025) | Protocol: Livesey and Marsh 2025 DMS benchmark: pairwise |Spearman| win rate, SNV-accessible substitutions only Dataset: Livesey and Marsh 2025 human DMS benchmark set (36 proteins) | 63.4% Pairwise win rate (average pairwise win rate against all other VEPs, |Spearman| with DMS on shared variants, SNV-accessible substitutions only) percent · higher Uncertainty: Not reported by the source: Bootstrap standard deviations appear only as Figure 2 error bars; not printed Coverage: 35/36 human DMS datasets (one per protein) with predictions for this VEP scored ('proteins' column, cell C31) | Independent external evaluation · Source checkedMethods, coverage and sourceLivesey and Marsh 2025 DMS benchmark: pairwise |Spearman| win rate, SNV-accessible substitutions only Aggregation: Not reported Livesey and Marsh 2025, Supplementary Material 2 (Tables S1-S8); Livesey and Marsh 2025, Genome Biology 26:104 (Europe PMC full text XML) · Supplementary Material 2, sheet 'Table S6', cell B31 (row 'MutScore', column 'rank_score') |
Source checking is not independent reproduction. Release 2026-10-22-1b7cf027e4f6.
Use this configuration
How it works, versions and access
Strengths, limitations and unresolved questions
Evidence
Source checking verifies the cited claim or transcription. It does not establish independent reproduction.
Evidence table
Inspect claims, sources and review details
Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.
One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.
0 evidence rows matching the loaded filters
| Property and statement | Original source and location | Review and provenance |
|---|
No evidence rows match these filters. Choose another scope or clear the search.
Sources and history
Release 2026-10-22-1b7cf027e4f6 · Record review: source checked
2 source records and release history
- Livesey and Marsh 2025, Supplementary Material 2 (Tables S1-S8) · Original source · 13059_2025_3575_MOESM2_ESM.xlsx as published with PMC12016141
- Livesey and Marsh 2025, Genome Biology 26:104 (Europe PMC full text XML) · Original source · PMC12016141 (published 2025-04-22; Genome Biol 26:104)
Technical metadata and extraction receipts
Stable ID: vep-lit-20261014-config-livesey2025-mutscore
- areas
- dna-genomes; proteins-complexes
- contexts
- research; clinical_research
- method types
- supervised_machine_learning
- reported name
- MutScore
- foundation model eligible
- false
- configuration type
- paper_evaluation
- version
- Predictions obtained from https://mutscorebatch-wgt7hvakhq-ew.a.run.app/ (Table S2 'Source'); release not stated
- training overlap
- Livesey and Marsh 2025 type: Clinical-trained
- access reuse
- Livesey and Marsh obtained predictions from: https://mutscorebatch-wgt7hvakhq-ew.a.run.app/
- source locator
- Supplementary Material 2, Table S2 row 54 ('MutScore'); printed label 'MutScore' in Tables S3 and S5-S8
- review
- reviewer: claude; reviewer note: Claude review agent; no human review claimed. Independent Claude (Opus 5.5) review agent, separate from the extraction agent that built this batch. Automated review only. Transcription, not reproduction.; reviewed at: 2026-10-14T15:30:00Z; artifact sha256: 1b0d792d1a5d3daa95545a7973cabb131c45e42c952e7e5a447a72deef1d1e70; retrieval url: https://static-content.springer.com/esm/art%3A10.1186%2Fs13059-025-03575-w/MediaObjects/13059_2025_3575_MOESM2_ESM.xlsx; method: ai-assisted-source-review; scope-review; method note: Descriptive fields, identity links and missing-metadata reasons checked against the cited sources.; note: Checked; see the dated review for rulings on identity and method type.
- provenance note
- MutScore as scored in the Livesey and Marsh 2025 VEP benchmark.
Related records
- configuration of: MutScore
- system: MutScore: Livesey and Marsh 2025 clinical benchmark: pairwise AUROC win rate, ClinVar pathogenic versus gnomAD missense
- system: MutScore: Livesey and Marsh 2025 DMS benchmark: pairwise |Spearman| win rate, all 36 DMS sets
- system: MutScore: Livesey and Marsh 2025 DMS benchmark: pairwise |Spearman| win rate, direct assays only
- system: MutScore: Livesey and Marsh 2025 DMS benchmark: pairwise |Spearman| win rate, indirect assays only
- system: MutScore: Livesey and Marsh 2025 DMS benchmark: pairwise |Spearman| win rate, SNV-accessible substitutions with gaps filled
- system: MutScore: Livesey and Marsh 2025 DMS benchmark: pairwise |Spearman| win rate, SNV-accessible substitutions only